0005

Northeast Pharmaceutical Group Co., Ltd. (000597)

Market Closed
18 Aug, 06:57
XSHE XSHE
¥
5. 86
+0.01
+0.17%
¥
8.23B Market Cap
- P/E Ratio
0.1% Div Yield
34,512,009 Volume
- Eps
¥ 5.85
Previous Close
Day Range
5.79 5.96
Year Range
3.99 6.69
Want to track 000597 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

000597 closed today higher at ¥5.86, an increase of 0.17% from yesterday's close, completing a monthly decrease of -6.54% or ¥0.41. Over the past 12 months, 000597 stock gained 11.41%.
000597 is not paying dividends to its shareholders.
The last earnings report, released on Apr 18, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.04%, based on the last three reports.
Northeast Pharmaceutical Group Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 20, 2020.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XSHE (CNY).

000597 Chart

Chart

Chart with 60 data points.
The chart has 1 X axis displaying categories.
The chart has 2 Y axes displaying values, and values.
End of interactive chart.

Northeast Pharmaceutical Group Co., Ltd. Dividends

0005
000597 1 month ago
Other
¥0.1 Per Share
0005
000597 23 May 2024
Other
¥0.1 Per Share
0005
000597 16 May 2023
Other
¥0.1 Per Share
0005
000597 27 May 2022
Other
¥0.01 Per Share
0005
000597 27 May 2021
Other
¥0.01 Per Share

Northeast Pharmaceutical Group Co., Ltd. Earnings

18 Apr 2025 Date
-
Cons. EPS
-
EPS
24 Oct 2024 Date
-
Cons. EPS
0.04
EPS
28 Aug 2024 Date
-
Cons. EPS
0.07
EPS
14 May 2024 Date
-
Cons. EPS
0.04
EPS
19 Apr 2024 Date
-
Cons. EPS
-
EPS
0005
000597 1 month ago
Other
¥0.1 Per Share
0005
000597 23 May 2024
Other
¥0.1 Per Share
0005
000597 16 May 2023
Other
¥0.1 Per Share
0005
000597 27 May 2022
Other
¥0.01 Per Share
0005
000597 27 May 2021
Other
¥0.01 Per Share
18 Apr 2025 Date
-
Cons. EPS
-
EPS
24 Oct 2024 Date
-
Cons. EPS
0.04
EPS
28 Aug 2024 Date
-
Cons. EPS
0.07
EPS
14 May 2024 Date
-
Cons. EPS
0.04
EPS
19 Apr 2024 Date
-
Cons. EPS
-
EPS

Northeast Pharmaceutical Group Co., Ltd. (000597) FAQ

What is the stock price today?

The current price is ¥5.86.

On which exchange is it traded?

Northeast Pharmaceutical Group Co., Ltd. is listed on XSHE.

What is its stock symbol?

The ticker symbol is 000597.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.1%.

What is its market cap?

As of today, the market cap is 8.23B.

Has Northeast Pharmaceutical Group Co., Ltd. ever had a stock split?

Northeast Pharmaceutical Group Co., Ltd. had 2 splits and the recent split was on May 20, 2020.

Northeast Pharmaceutical Group Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Yonggang Cai CEO
XSHE Exchange
CNE0000009G0 ISIN
CN Country
5,964 Employees
- Last Dividend
20 May 2020 Last Split
9 May 1996 IPO Date

Overview

Northeast Pharmaceutical Group Co., Ltd. is a substantial enterprise situated in Shenyang, China, founded in 1946. The company operates across various sectors within the pharmaceutical industry, including chemical raw materials, chemical preparations, pharmaceuticals, pharmaceutical engineering, biomedicine, and more. With a firm foundation in China, Northeast Pharmaceutical Group has diversified its business to encompass a broad range of products and services, from vitamin products to in vitro biological diagnostic reagents. Moreover, the company has expanded its operations to include a medical distribution business, positioning itself as a comprehensive provider in the pharmaceutical and healthcare sectors.

Products and Services

The product portfolio of Northeast Pharmaceutical Group Co., Ltd. is extensive, encompassing various health-related fields:

  • Vitamin Products: This includes vitamin C, vitamin B1, vitamin B6, and levocarnitine series, essential for maintaining health and preventing nutrient deficiencies.
  • Anti-infection Products: The company offers a range of antibiotics and treatments, such as fosfomycin series, azithromycin series, berberine hydrochloride, chloramphenicol, and other related products, addressing various infections.
  • Reproductive System and Sex Hormone Products: These comprise carprost, carboprost tromethamine, dapoxetine hydrochloride, and levonorgestrel and tadalafil tablets, catering to reproductive health and conditions.
  • Nervous System Products: Including piracetam series, levetiracetam series, vinpocetine, among others, these products are developed to support neurological health and function.
  • Essence and Cannabis-Containing Series Products: Offering morphine hydrochloride injection, pethidine hydrochloride injection, compound codeine phosphate syrup, morphine hydrochloride tablets, and oxycodone hydrochloride injection, focusing on pain management and palliative care.
  • Anti-AIDS Products: Comprising kedu/zidovudine tablets, efavirenz tablets, and others, these products are directed at managing HIV/AIDS.
  • Digestive System Products: Including bacillus licheniformis, aluminum magnesium carbonate chewable tablets, among others, addressing various digestive system conditions.
  • In Vitro Biological Diagnostic Reagent Products: Such as HIV, HBV, HCV, HPV, and TB molecular diagnostic reagents. These are critical for the detection and management of these diseases through laboratory tests.
  • General Health Products: Offering chondroitin ammonia sulfate collagen D3 calcium capsules, protein powder, and probiotic powder, which are geared towards overall health and well-being.
  • Additional Pharmaceuticals: The company also manufactures a wide assortment of other drugs, including amlodipine maleate, narcotine syrup, xiaoke citridin tablets, acetaminophen tablets, qutong tablets, metronidazole tablets, tinidazole tablets, and amphenamine tablets, covering a wide range of therapeutic areas.
  • Specialized Medicine Series: Covering obstetrics and gynecology system, urinary system, antiviral, cardiovascular and cerebrovascular, analgesic and analgesic, and biological diagnosis series medicines, Northeast Pharmaceutical Group Co., Ltd. addresses specific medical needs across various fields.

In addition to its extensive product lineup, the company is actively involved in the medical distribution business, enhancing its role in the pharmaceutical and healthcare ecosystem.

Contact Information

Address: No. 8, Kunming Lake Street, Shenyang, China, 110027
Phone: 86 24 2580 6963